OSR HEALTH, INC. Other Current Liabilities
OSR HEALTH, INC. (OSRH) had Other Current Liabilities of $966.70 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Other Liabilities, Current $966.70K.
- 2026-03-31: Other Liabilities, Current $978.22K.
- 2025-12-31: Other Liabilities, Current $971.45K.
- 2025-09-30: Other Liabilities, Current $963.32K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $966.70K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $978.22K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $971.45K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $963.32K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.13M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.00M 10-Q · filed 2025-05-20 | |
| 2024-12-31 | $79.78K 10-K · filed 2026-03-31 | $72.00K 10-K · filed 2025-04-22 |
| 2024-09-30 | $87.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $97.00K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $87.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $72.00K 10-K · filed 2025-04-22 | |
| 2023-09-30 | $17.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $17.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $17.00K 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $17.00K 10-K · filed 2024-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |